Skip to content

Lifeline Endocardial Bipolar Lead 484-03

by Intermedics, Inc. 510(k)

Active United States

510(k) K853519

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853519 Date24 Oct 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lifeline Endocardial Bipolar Lead 484-03 is a permanent pacemaker electrode designed for endocardial placement. It delivers bipolar pacing and sensing capabilities within the heart, facilitating cardiac rhythm management for patients requiring chronic pacing support.

This lead is intended for use with compatible pacemaker systems and is supplied sterile for single-use implantation. It is classified as a Class III device under FDA regulations and has received 510(k) clearance through a traditional review pathway. The device is intended for cardiovascular applications and adheres to regulatory standards outlined in 21 CFR 870.3680.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Lifeline Endocardial Bipolar Lead 484-03, and how does it function within the body?

    The Lifeline Endocardial Bipolar Lead 484-03 is designed for endocardial placement inside the heart to provide bipolar pacing and sensing. This means it delivers electrical impulses to regulate heart rhythm and detects cardiac signals, supporting patients who require chronic pacing for conditions like bradycardia or heart block. The lead connects to compatible pacemaker systems to maintain stable cardiac function.

  • Is this lead intended for single-use or reusable implantation, and how is it supplied?

    This lead is sterile and intended for single-use only after implantation. It is supplied pre-sterilized to ensure safety and reliability during surgical procedures, eliminating the need for reprocessing or reuse.

  • What regulatory pathway was followed for FDA clearance of this device, and what classification does it hold?

    The Lifeline Endocardial Bipolar Lead 484-03 was cleared through the traditional 510(k) review pathway by the FDA. It is classified as a Class III device, which requires premarket approval or 510(k) clearance due to its role in life-sustaining or life-supporting functions, such as cardiac rhythm management.

  • Are there multiple models or sizes available for this lead, and how would a clinician determine the correct fit for a patient?

    The provided data does not specify variations in sizes or models for this particular lead (484-03). However, like most endocardial leads, selection typically depends on factors such as patient anatomy, pacing requirements, and compatibility with the implanted pacemaker system. Clinicians would consult manufacturer guidelines or product documentation for specific sizing recommendations based on the patient’s needs.